Safety and Efficacy of BION-1301 in Adults with IgA Nephropathy
Age: 18 years - 66+
Gender: All
We've found 10 total result s for "Kidney Diseases".
The primary study objective is to evaluate the benefit of the Sirolimus eluting Collagen implant (SeCI; Sirogen), a single dose prophylactic treatment delivered intraoperatively at the time of surgical creation of an arteriovenous fistula for hemodialysis vascular a...
Age: 65 years - 66+
Gender: All
This is an open-label Phase 2 study evaluating the long term safety and tolerability of GFB-887 in patients with focal segmental glomerulosclerosis (FSGS), and treatment-resistant minimal change disease (TR-MCD)
Age: 18 - 75 years
Gender: All
The purpose of this study is to assess the impact of the KidneyIntelX assay utilized as part of the current standard of care on the management of patients seen in the primary care physician's office at Mount Sinai.
Age: 23 years - 66+
Gender: All
Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
- Neoplasm Metastasis
- Kidney Diseases
- Renal Insufficiency, Chronic
- Hyperparathyroidism
- Hyperparathyroidism, Secondary
Age: Birth - 18 years
Gender: All
This is a Phase 3 Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
- Neoplasm Metastasis
- Kidney Diseases
- Renal Insufficiency, Chronic
- Hyperparathyroidism
- Hyperparathyroidism, Secondary
Age: 0 - 18 years
Gender: All
Primary Objectives: To evaluate the safety (compared to iron sucrose) and efficacy of ferumoxytol in pediatric CKD subjects with iron deficiency anemia (IDA) or who are at risk of development of IDA Secondary Objective: To determine the single-dose pharmac...
- Kidney Diseases
- Renal Insufficiency, Chronic
- Anemia
- Anemia, Iron-Deficiency
- Iron Deficiencies
- Deficiency Diseases
Age: 2 - 17 years
Gender: All
The APOLLO study is being done in an attempt to improve outcomes after kidney transplantation and to improve the safety of living kidney donation based upon variation in the apolipoprotein L1 gene (APOL1). Genes control what is inherited from a family, such as eye ...
Age: Birth - 66+
Gender: All
This parallel-group, randomized, placebo-controlled study will examine the incidence and severity of acute kidney injury (AKI) in patients with chronic kidney disease (CKD) stage III/IV following an i.v. injection of iso-osmolar iodinated contrast material iodixanol ...
Age: 18 years - 66+
Gender: All
This is a prospective, observational, cohort study of patients with a clinical diagnosis of diabetes who are undergoing clinically indicated kidney biopsy. The intent is to collect, process, and study kidney tissue and to harvest blood, urine and genetic materials t...
Age: 18 - 100 years
Gender: All